Oruka Therapeutics (ORKA) Amortizatization of Intangibles (2015 - 2026)
Oruka Therapeutics (ORKA) posted quarterly Amortizatization of Intangibles of $446000.0 for Q1 2026, down 75.18% year-over-year from $1.8 million in Q1 2025, and down 32.73% quarter-over-quarter from $663000.0 in Q4 2025.
Powered by 
Analysis
Oruka Therapeutics (ORKA) Amortizatization of Intangibles (2015 - 2026) Analysis & Trends
Oruka Therapeutics' Amortizatization of Intangibles history runs 6 years deep, the most recent figure standing at $446000.0 for Q1 2026.
- In Q1 2026, Amortizatization of Intangibles fell 75.18% year-over-year to $446000.0; the TTM figure through Mar 2026 stood at $3.7 million (up 103.23% YoY), while the FY2025 annual figure was $5.0 million, up 122.85% from the prior year.
- Amortizatization of Intangibles for Q1 2026 stood at $446000.0, down from $663000.0 in the prior quarter.
- The five-year high for Amortizatization of Intangibles was $1.8 million in Q1 2025, with the low at $446000.0 in Q1 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 4.33 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 678,000.00 |
| 10 | Oruka Therapeutics | 5.85 Bn | 4.12 Bn | - | 955,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 955,000.00 |
| Mar 31, 2026 | 446,000.00 |
| Dec 31, 2025 | 663,000.00 |
| Sep 30, 2025 | 1.04 Mn |
| Jun 30, 2025 | 1.50 Mn |
| Mar 31, 2025 | 1.80 Mn |
| Jun 30, 2024 | 9,000.00 |
| Mar 31, 2024 | 16,000.00 |
| Dec 31, 2023 | 20,000.00 |
| Sep 30, 2023 | 26,000.00 |
| Jun 30, 2023 | 25,000.00 |
| Mar 31, 2023 | 25,000.00 |
| Dec 31, 2022 | 24,000.00 |
| Sep 30, 2022 | 24,000.00 |
| Jun 30, 2022 | 23,000.00 |
| Mar 31, 2022 | 23,000.00 |
| Dec 31, 2021 | 23,000.00 |
| Sep 30, 2021 | 22,000.00 |
| Jun 30, 2021 | 16,000.00 |
| Mar 31, 2021 | 14,000.00 |